Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD).

NCT04626947 is registered in ClinicalTrials.gov with David Binion, MD as lead sponsor.

NCT NCT04626947
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04626947 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD).
Lead sponsor
David Binion, MD
Phase
Phase 4
Overall status
Terminated
Start date
October 14, 2021
Completion date
May 31, 2024
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

c. diff. infections, crohn disease, inflammatory bowel diseases, ulcerative colitis